After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Secretary Robert F. Kennedy Jr., who leads the Department of Health and Human Services, will soon announce the changes to the ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The federal judge’s ruling has nothing to do with the merits of Kobach’s scientifically dubious argument that the vaccine isn ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

A European Union court on Wednesday annulled a decision to withhold text messages exchanged between European Commission ...

Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

Headache and fatigue were the most commonly reported incident adverse events of the AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine in real-world settings across the United Kingdom; anosmia (loss of ...